Cel-Sci Corporation

AMEX: CVMHealthcare / Biotechnology / USA
8.48-0.0600-0.70%Vol 656 3241Y Perf 144.08%
Sep 20th, 2019 16:00
BID8.50 ASK8.60
Open8.64 Previous Close8.54
Pre-Market- After-Trading8.49
 - -%  0.01 0.12%
Target Price
14.00 
Analyst Rating
Hold 3.00
Potencial %
65.09 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/33/50 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-47/-42 
Growth Ranking
★+ —    -
Insiders Shares Cnt. % 3/6/12M
-100/-33/-23 
Income Ranking
 —    -
Market Cap (mil)295 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
84.04 
Earnings Date
13th Aug 2019

Today's Price Range

8.488.72

52wk Range

2.379.64

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
5.08%
1 Month
0.59%
3 Months
5.60%
6 Months
168.35%
1 Year
144.08%
3 Years
-22.91%
5 Years
-61.89%
10 Years
-98.24%

Name / TickerPriceChg.Chg.%
CVM8.48-0.0600-0.70
AAPL217.73-3.2300-1.46
GOOG1 229.93-8.7800-0.71
MSFT139.44-1.6300-1.16
XOM72.08-0.2500-0.35
WFC48.63-0.2800-0.57
JNJ131.651.54001.18
FB189.93-0.2100-0.11
GE9.37-0.0500-0.53
JPM118.90-0.4800-0.40
Earnings HistoryEstimateReportedSurprise %
Q03 2019-0.10-0.37-270.00
Q02 2019-0.12-0.19-58.33
Q01 2019--0.17-
Q04 2018--0.70-
Q03 2018--0.36-
Q02 2018--0.31-
Q01 2018--0.53-
Q04 2017--0.58-
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.090.00-
9/2019 QR-0.090.00-
9/2019 FY-0.82-74.47Negative
9/2020 FY-0.300.00-
Next Report Date-
Estimated EPS Next Report-0.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume656 324
Shares Outstanding (in ths.)34 805
Trades Count1 889
Dollar Volume4 509 395
Avg. Volume710 439
Avg. Weekly Volume1 092 231
Avg. Monthly Volume692 298
Avg. Quarterly Volume761 213
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEO: Geert R. Kersten

Teplephone: +1 703 506-9460

Address: 8229 Boone Boulevard, Vienna 22182, VA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

79%21%

Bearish Bullish

65%35%

Bearish Bullish

61%39%

News